Ligand Pharmaceuticals, Inc. (LGND)
286.94
+2.67
(+0.94%)
USD |
NASDAQ |
Sep 02, 16:00
286.94
0.00 (0.00%)
After-Hours: 19:41
Ligand Pharmaceuticals Net Income (TTM) : 197.22M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 197.22M |
| March 31, 2026 | 153.56M |
| December 31, 2025 | 124.45M |
| September 30, 2025 | 48.58M |
| June 30, 2025 | -75.86M |
| March 31, 2025 | -132.62M |
| December 31, 2024 | -4.032M |
| September 30, 2024 | 45.24M |
| June 30, 2024 | 42.14M |
| March 31, 2024 | 96.34M |
| December 31, 2023 | 53.82M |
| September 30, 2023 | 21.10M |
| June 30, 2023 | 41.02M |
| March 31, 2023 | 51.32M |
| December 31, 2022 | -5.219M |
| September 30, 2022 | 6.121M |
| June 30, 2022 | 10.20M |
| March 31, 2022 | 28.32M |
| December 31, 2021 | 59.36M |
| September 30, 2021 | 68.32M |
| June 30, 2021 | 47.89M |
| March 31, 2021 | 39.25M |
| December 31, 2020 | -2.985M |
| September 30, 2020 | -16.11M |
| June 30, 2020 | -24.66M |
| Date | Value |
|---|---|
| March 31, 2020 | -61.17M |
| December 31, 2019 | 629.30M |
| September 30, 2019 | 594.18M |
| June 30, 2019 | 676.80M |
| March 31, 2019 | 764.38M |
| December 31, 2018 | 143.32M |
| September 30, 2018 | 178.79M |
| June 30, 2018 | 119.86M |
| March 31, 2018 | 52.75M |
| December 31, 2017 | 12.55M |
| September 30, 2017 | 16.44M |
| June 30, 2017 | 9.062M |
| March 31, 2017 | -3.166M |
| December 31, 2016 | -2.368M |
| September 30, 2016 | 7.099M |
| June 30, 2016 | 205.21M |
| March 31, 2016 | 233.41M |
| December 31, 2015 | 227.44M |
| September 30, 2015 | 227.84M |
| June 30, 2015 | 29.45M |
| March 31, 2015 | 8.709M |
| December 31, 2014 | 10.90M |
| September 30, 2014 | 6.031M |
| June 30, 2014 | 7.219M |
| March 31, 2014 | 9.625M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |
| Zevra Therapeutics, Inc. | 56.00M |
| Liquidia Corp. | 138.61M |